| 000 | 01488 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517105358.0 | ||
| 264 | 0 | _c20180112 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.10538 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Wei-Lin | |
| 245 | 0 | 0 |
_aMelatonin suppresses autophagy in type 2 diabetic osteoporosis. _h[electronic resource] |
| 260 |
_bOncotarget _cAug 2016 |
||
| 300 |
_a52179-52194 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutophagy _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelatonin _xpharmacology |
| 650 | 0 | 4 |
_aOsteoblasts _xdrug effects |
| 650 | 0 | 4 |
_aOsteogenesis _xdrug effects |
| 650 | 0 | 4 |
_aOsteoporosis _xprevention & control |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aMeng, Hong-Zheng | |
| 700 | 1 | _aYang, Rui-Fei | |
| 700 | 1 | _aYang, Mao-Wei | |
| 700 | 1 | _aSun, Guang-Hong | |
| 700 | 1 | _aLiu, Jun-Hua | |
| 700 | 1 | _aShi, Peng-Xu | |
| 700 | 1 | _aLiu, Fei | |
| 700 | 1 | _aYang, Bo | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 32 _gp. 52179-52194 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.10538 _zAvailable from publisher's website |
| 999 |
_c26246821 _d26246821 |
||